Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

881.31
-15.6900-1.75%
Volume:1.66M
Turnover:1.48B
Market Cap:833.18B
PE:38.40
High:900.83
Open:896.31
Low:880.80
Close:897.00
52wk High:1,133.95
52wk Low:623.78
Shares:945.38M
Float Shares:945.00M
Volume Ratio:0.61
T/O Rate:0.18%
Dividend:6.00
Dividend Rate:0.68%
EPS(TTM):22.95
EPS(LYR):22.95
ROE:101.16%
ROA:19.42%
PB:31.40
PE(LYR):38.40

Loading ...

Eli Lilly Weight Loss Push Weighs On Valuation And Growth Hopes

Simply Wall St.
·
Mar 24

BRIEF-Eli Lilly Discontinuing Some Insulin Presentations In Selected Countries, Says EMA

Reuters
·
Mar 24

What's Going On With Eli Lilly On Monday?

Benzinga_recent_news
·
Mar 24

Ema: All Discontinuations Expected to Occur Before Q2 2027, After Which Affected Insulin Presentations Will No Longer Be Available

THOMSON REUTERS
·
Mar 24

Ema: Eli Lilly Is Discontinuing Some of Its Insulin Presentations Across Selected Countries - Website

THOMSON REUTERS
·
Mar 24

Market Chatter: Takeda, Eli Lilly to Face Class Action Over Actos Cancer Risk

MT Newswires Live
·
Mar 23

BRIEF-30 Executives Of U.S. Companies, Including Mcdonald's, Eli Lilly, Coach Parent Tapestry, And Mastercard Attended China Development Forum - CNBC

Reuters
·
Mar 23

J.P. Morgan Keeps Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
Mar 23

Eli Lilly Chairman Calls for Designating This Year as "Weight Management Year"

Deep News
·
Mar 23

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and The Ensign Group (ENSG)

TIPRANKS
·
Mar 22

Eli Lilly & Co Slides as Bold Pipeline Tested

TIPRANKS
·
Mar 21

Eli Lilly CEO David Ricks' pay rises 26% for 2025

Reuters
·
Mar 21

Eli Lilly & Co. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 21

Eli Lilly Says CEO David a. Ricks's 2025 Total Compensation Was $36.7 Mln - SEC Filing

THOMSON REUTERS
·
Mar 21

Sector Update: Health Care Stocks Retreat Friday Afternoon

MT Newswires Live
·
Mar 21

Eli Lilly Advances Digital Sleep Tech Study in Early Alzheimer’s Tracking

TIPRANKS
·
Mar 21

Eli Lilly’s New Diabetes Candidate LY3549492 Advances With Completion of Early-Stage Study in Japan

TIPRANKS
·
Mar 21

BMO Capital Remains a Buy on Eli Lilly & Co (LLY)

TIPRANKS
·
Mar 20

Market Chatter: Eli Lilly Alzheimer's Drug to be Reconsidered by UK Health Regulator

MT Newswires Live
·
Mar 20

Eli Lilly Wins Appeal for Alzheimer's Drug, Prompting NHS Review of Coverage

Stock News
·
Mar 20